These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24607231)

  • 41. Endocannabinoids mediate synaptic plasticity at glutamatergic synapses on spiny neurons within a basal ganglia nucleus necessary for song learning.
    Thompson JA; Perkel DJ
    J Neurophysiol; 2011 Mar; 105(3):1159-69. PubMed ID: 21177997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission.
    Liu J; Yu B; Neugebauer V; Grigoriadis DE; Rivier J; Vale WW; Shinnick-Gallagher P; Gallagher JP
    J Neurosci; 2004 Apr; 24(16):4020-9. PubMed ID: 15102917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developmental increase in hippocampal endocannabinoid mobilization: role of metabotropic glutamate receptor subtype 5 and phospholipase C.
    Liang SL; Alger BE; McCarthy MM
    J Neurophysiol; 2014 Nov; 112(10):2605-15. PubMed ID: 25185819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
    Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG
    J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Astrocytes in endocannabinoid signalling.
    Navarrete M; Díez A; Araque A
    Philos Trans R Soc Lond B Biol Sci; 2014 Oct; 369(1654):20130599. PubMed ID: 25225093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.
    Domenici MR; Azad SC; Marsicano G; Schierloh A; Wotjak CT; Dodt HU; Zieglgänsberger W; Lutz B; Rammes G
    J Neurosci; 2006 May; 26(21):5794-9. PubMed ID: 16723537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release.
    Hashimotodani Y; Ohno-Shosaku T; Watanabe M; Kano M
    J Physiol; 2007 Oct; 584(Pt 2):373-80. PubMed ID: 17615097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocannabinoids and synaptic function in the CNS.
    Hashimotodani Y; Ohno-Shosaku T; Kano M
    Neuroscientist; 2007 Apr; 13(2):127-37. PubMed ID: 17404373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice.
    Kortleven C; Fasano C; Thibault D; Lacaille JC; Trudeau LE
    Eur J Neurosci; 2011 May; 33(10):1751-60. PubMed ID: 21410793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala.
    Huang YC; Wang SJ; Chiou LC; Gean PW
    J Neurosci; 2003 Nov; 23(32):10311-20. PubMed ID: 14614090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons.
    Haj-Dahmane S; Shen RY
    J Physiol; 2010 Jul; 588(Pt 14):2589-604. PubMed ID: 20498231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developmental changes in retrograde messengers involved in depolarization-induced suppression of excitation at parallel fiber-Purkinje cell synapses in rodents.
    Crepel F
    J Neurophysiol; 2007 Jan; 97(1):824-36. PubMed ID: 17108093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular composition of the endocannabinoid system at glutamatergic synapses.
    Katona I; Urbán GM; Wallace M; Ledent C; Jung KM; Piomelli D; Mackie K; Freund TF
    J Neurosci; 2006 May; 26(21):5628-37. PubMed ID: 16723519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocannabinoid signaling and synaptic plasticity in the brain.
    Zhu PJ
    Crit Rev Neurobiol; 2006; 18(1-2):113-24. PubMed ID: 17725514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuronal populations mediating the effects of endocannabinoids on stress and emotionality.
    Häring M; Guggenhuber S; Lutz B
    Neuroscience; 2012 Mar; 204():145-58. PubMed ID: 22233782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noncanonical Activity of Endocannabinoids and Their Receptors in Central and Peripheral Synapses.
    Balezina OP; Tarasova EO; Gaydukov AE
    Biochemistry (Mosc); 2021 Jul; 86(7):818-832. PubMed ID: 34284706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress.
    Wang W; Sun D; Pan B; Roberts CJ; Sun X; Hillard CJ; Liu QS
    Neuropsychopharmacology; 2010 Oct; 35(11):2249-61. PubMed ID: 20664582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term depression of inhibitory synaptic transmission induced by spike-timing dependent plasticity requires coactivation of endocannabinoid and muscarinic receptors.
    Ahumada J; Fernández de Sevilla D; Couve A; Buño W; Fuenzalida M
    Hippocampus; 2013 Dec; 23(12):1439-52. PubMed ID: 23966210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocannabinoids mediate bidirectional striatal spike-timing-dependent plasticity.
    Cui Y; Paillé V; Xu H; Genet S; Delord B; Fino E; Berry H; Venance L
    J Physiol; 2015 Jul; 593(13):2833-49. PubMed ID: 25873197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.